Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.38 | N/A |
| PEG Ratio (TTM) | 0.64 | N/A |
| P/S Ratio (TTM) | 0.67 | N/A |
| P/B Ratio (TTM) | 1.83 | N/A |
| P/FCF Ratio (TTM) | 8.81 | N/A |
| Price to 5YR AVG Earnings Ratio | 54.67 | N/A |
| Price to 5YR AVG FCF Ratio | 49.32 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.18% | N/A |
| ROE (TTM) | 9.37% | N/A |
| Net Profit Margin (TTM) | 3.30% | N/A |
| ROIC 5YR AVG | 5.14% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 102.07% | 40.81% | 194.07% |
| Revenue | 2.53% | 8.96% | 0.81% |
| Net Income | 105.48% | 37.19% | 156.07% |
| Cash Flow | 259.56% | 6.02% | 48.87% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.84 | N/A |
| Quick Ratio (TTM) | 1.04 | N/A |
| D/E Ratio (TTM) | 0.07 | N/A |
| Interest Coverage (TTM) | 20.30 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 4.69 | N/A |
| LTL to 5YR AVG FCF | 10.93 | N/A |
| Shares Outstanding Growth 5YR AVG | -7.85% | N/A |